IP Verse

Synergistic Anti-Cd47 Therapy For Hematologic Cancers - EP2477648B1

PatentPatent Analysis

EP2477648

THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Application Number
EP10817793A
Filing Date
Sep 15, 2010
Status
Granted And Under Opposition
Jun 17, 2022
Grant Date
Jul 20, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP4069368B1
EP3341015B2
EP3147295B2

Bibliography

The patent EP2477648B1 was granted to The Board OF Trustees OF The Leland Stanford Junior University on Jul 20, 2022 following the initial filing on Sep 15, 2010 under the application number EP10817793A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

JG OPPOSITIONSApr 19, 2023ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents